亚虹医药成立于2010年3月,是一家专注于泌尿生殖系统肿瘤及其它重大疾病领域的全球化创新药公司。 秉承“改善人类健康,让生命更有尊严”的企业使命,亚虹立志成为在专注治疗领域集研发、生产和商业化为一体的国际领先制药企业,为中国和全球患者提供最佳的诊疗一体化解决方案。
Total raised: $106M
Founded date: 2010
Investors 3
Date | Name | Website |
- | triwise | en.triwise... |
- | Qiming Ven... | qimingvent... |
21.11.2020 | Qiming Ven... | qimingvc.c... |
Funding Rounds 1
Date | Series | Amount | Investors |
11.11.2020 | - | $106M | Qiming Ven... |
Mentions in press and media 3
Date | Title | Description | Source |
18.05.2023 | Asieris Deepens Strategic Partnership with UroViu to Further... | SHANGHAI, May 18, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company ... | en.prnasia... |
11.11.2020 | China’s Asieris Pharmaceuticals bags over $106m funding led ... | Genitourinary tumour therapy developer Asieris Pharmaceuticals has closed a Series D round of financ... | dealstreet... |
11.11.2020 | China’s Asieris Pharmaceuticals bags over $106m funding led ... | Premium Genitourinary tumour therapy developer Asieris Pharmaceuticals has closed a Series D round ... | dealstreet... |